KLK3 and neoplasm: In the current clinical setting for biopsy decision, the ability of the PSA glycoprofile to identify significant cancer could improve the accuracy of the preselection of men who have to undergo expensive imaging and subsequent biopsy, thus reducing costs and the number of negative biopsies without loss of significant tumor cases.